Quick Heal Technologies Ltd

AGM notice and voting

• Intimates 31st AGM to be held Sep 23, 2026 via video conferencing.
• Notice and Annual Report for FY2025-26 to be circulated separately within timelines.
• Remote e-voting from Sep 19, 2026 9:00 to Sep 22, 2026 17:00 IST.
• E-voting closes at 5:00 PM IST on Sep 22, 2026.
• Cut-off date for voting eligibility: Sep 17, 2026.
• Members to update email addresses with DP or RTA for communications.

ESOP grant details

• The NRC approved grant of 102,000 ESOPs under ESOP Scheme 2021 on Aug 11, 2026.
• The grant complies with SEBI SBEB Regulations 2021.
• 102,000 options exercisable into 102,000 equity shares of ₹10 each.
• Exercise price ₹76 per option (50% discount to NSE close on 10 Aug 2026).
• Vesting: minimum 1 year, maximum 4 years from grant date.
• All vested options exercisable within 3 years from vesting.
• No options exercised or money realized yet.
• Options vesting window: 1–4 years from grant; equal share entitlement on exercise.
• Disclosure under SEBI LODR Reg 30.

Appointment: SVP - Enterprise Sales

• Effective August 11, 2026, Rajiv Sreekantan appointed Senior Vice President - Enterprise Sales.
• Change type: Appointment; Rajiv Sreekantan appointed SVP - Enterprise Sales.
• Reason: Nomination and Remuneration Committee recommendation.
• Profile: 30+ years in enterprise technology sales, including 26 years at IBM.
• Relationships with other directors: Not Applicable.
• Term: Not specified.
• Impact on governance: No board/committee changes disclosed.

Resignation of Senior VP – Enterprise Sales

• Type of change: resignation of Samuel Sathyajith, SVP—Enterprise Sales
• Resignation date: August 11, 2026
• Cessation date: on or before September 4, 2026
• Reason: to pursue the next phase of his professional journey

Board decisions and results

• Board approved unaudited consolidated and standalone results for the quarter ended 30 June 2026.
• Limited Review Report from MSKA & Associates LLP issued with an unmodified opinion.
• Richard Stiennon re-appointed as Non-Executive Independent Director for a second five-year term, subject to AGM approval.

Governance and operations changes

• Harish Kumar G S appointed Chief Executive Officer w.e.f June 18, 2026.
• Registered Office moved within Pune; Books of Accounts relocated to Yerwada Corporate Office.
• Subsidiaries include Quick Heal Technologies America Inc and Seqrite Technologies DMCC.

Financial highlights and notes

• Consolidated Q1 FY27 revenue from operations ₹44.99 Cr; total income ₹59.09 Cr.
• PAT and EBITDA: Consolidated ₹(5.28) Cr; EBITDA ₹(17.6) Cr; margin -39.1%.
• Order book ₹56 Cr+; deferred revenue ₹52.3 Cr; overdues down since H1 FY26.
• New Labour Codes increased employee benefit expense by ₹1.33 Cr in FY2026.

Resignation of Chief Product Officer

• Dr. Lalit Mohan Sanagavarapu, Chief Product Officer, resigned effective August 7, 2026.
• Reason: Personal reasons.

Dematerialisation activity

• No dematerialisation/rematerialisation requests were received; no processing was required.